Dr. Beygi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
875 Blake Wilbur Dr
Palo Alto, CA 94305- Is this information wrong?
Summary
- Dr. Sara Beygi is a hematologist oncologist in Palo Alto, CA. She received her medical degree from Tehran University of Medical Sciences and has been in practice 11 years. She specializes in hematology and oncology and has expertise in lymphoid malignancies. She has numerous publications and citations.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2018 - 2021
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2015 - 2018
- Tehran Univerisiry of Medical SciencesClass of 2013
Certifications & Licensure
- CA State Medical License 2018 - 2025
- PA State Medical License 2015 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Research Training Award for Fellows American Society of Hematology (ASH), 2021
- Summa cum laude Tehran University of Medical Sciences, 2013
Publications & Presentations
PubMed
- 42 citationsDeterminants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.Brian J Sworder, David M Kurtz, Stefan K Alig, Matthew J Frank, Navika Shukla
Cancer Cell. 2023-01-09 - 11 citationsTreatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study.Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel
Haematologica. 2023-03-01 - 5 citationsA 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma.M Lia Palomba, Paola Ghione, Anik R Patel, Myrna Nahas, Sara Beygi
Expert Review of Anticancer Therapy. 2023-02-01
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: